デフォルト表紙
市場調査レポート
商品コード
1728092

家禽用ワクチン市場- 世界の産業規模、シェア、動向、機会、予測、用途別、製品タイプ別、疾患タイプ別、地域別、競合別、2020-2030年

Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Product, By Disease Type, By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
家禽用ワクチン市場- 世界の産業規模、シェア、動向、機会、予測、用途別、製品タイプ別、疾患タイプ別、地域別、競合別、2020-2030年
出版日: 2025年05月16日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

家禽用ワクチンの世界市場は、2024年には18億9,000万米ドルとなり、2030年には27億8,000万米ドルに達すると予測され、予測期間中のCAGRは6.64%で成長すると予測されています。

養鶏は依然として世界の食糧供給の要であるため、家禽用ワクチン市場は群れの健康維持と食糧安全保障に重要な役割を果たしています。伝染性滑液包病（IBD）のような鳥類疾病の流行の増加は、家禽製品の人気の高まりと相まって、効果的な免疫戦略の需要を促進しています。特にアフリカやアジアのような地域では、最近の人獣共通感染症の発生や家禽のウイルス感染率の上昇が、広範なワクチン接種プログラムの必要性をさらに強調しています。組み換えワクチンやDNAベースワクチンなど、ワクチン開発における技術的進歩が市場の発展に寄与しています。さらに、政府および獣医組織は、養鶏業界における経済的損失を防ぐため、疾病対策にますます重点を置くようになっており、養鶏における生産性と健康基準を維持するためのワクチンの重要性を強化しています。

市場概要
予測期間 2026-2030
市場規模：2024年 18億9,000万米ドル
市場規模：2030年 27億8,000万米ドル
CAGR：2025年～2030年 6.64%
急成長セグメント 弱毒生ワクチン
最大市場 北米

市場促進要因

世界の家禽消費量の増加

主な市場課題

疾病の複雑性と多様性

主要市場動向

精密ワクチン接種

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の家禽用ワクチン市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 用途別（ブロイラー、レイヤー、ブリーダー）
    • 製品別（弱毒生ワクチン、不活化ワクチン、サブユニットワクチン、DNAワクチン、組み換えワクチン）
    • 疾患別（感染性気管支炎、感染性滑液包疾患、感染性喉頭気管炎、卵落下症候群、アデノウイルス、アヒルウイルス性腸炎、封入体肝炎、サルモネラ菌、その他）
    • 地域別
    • 企業別（2024）
  • 製品市場マップ
    • 用途別
    • 製品別
    • 疾患タイプ別
    • 地域別

第6章 北米の家禽用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の家禽用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン

第8章 アジア太平洋地域の家禽用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国

第9章 南米の家禽用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの家禽用ワクチン市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 合併と買収
  • 製品上市

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corporation

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 16323

The Global Poultry Vaccines Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.78 billion by 2030, growing at a CAGR of 6.64% during the forecast period. As poultry farming remains a cornerstone of the global food supply, the market for poultry vaccines plays a vital role in maintaining flock health and ensuring food security. The increasing prevalence of avian diseases, such as Infectious Bursal Disease (IBD), coupled with the growing popularity of poultry products, is driving the demand for effective immunization strategies. Recent zoonotic outbreaks and the rising incidence of viral infections in poultry, particularly in regions like Africa and Asia, are further emphasizing the need for widespread vaccination programs. Technological advancements in vaccine development, including recombinant and DNA-based vaccines, are contributing to the market's evolution. Moreover, governments and veterinary organizations are increasingly focused on disease control to prevent economic losses in the poultry industry, reinforcing the importance of vaccines in sustaining productivity and health standards in poultry farming.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.89 Billion
Market Size 2030USD 2.78 Billion
CAGR 2025-20306.64%
Fastest Growing SegmentAttenuated Live Vaccine
Largest MarketNorth America

Key Market Drivers

Rising Global Poultry Consumption

The steady increase in global poultry consumption is significantly contributing to the expansion of the poultry vaccines market. Poultry, particularly chicken, has become a preferred protein source due to its affordability, nutritional value, and adaptability in diverse cuisines. As populations grow and urbanization accelerates, the demand for poultry meat and eggs continues to rise. This surge in consumption amplifies the need for disease prevention to protect flock health and ensure stable supply chains. Poultry farming is highly susceptible to disease outbreaks, which can result in massive financial losses and disruptions in production. Diseases like Newcastle disease, avian influenza, and coccidiosis are particularly prevalent and costly. For instance, a study reported in IJCMAS in October 2021 detailed financial losses ranging from INR 17,864 (USD 214) to INR 2,66,080 (USD 3,188.89) per farm due to Newcastle disease, further highlighting the critical need for robust vaccination programs. As a result, maintaining flock health through vaccination is becoming a key strategy for producers to safeguard economic returns and meet growing consumer demand.

Key Market Challenges

Disease Complexity and Variability

The poultry vaccines market faces notable challenges stemming from the complexity and variability of infectious diseases affecting poultry. Poultry are vulnerable to a broad spectrum of pathogens, including viruses, bacteria, and parasites, each with multiple strains and high mutation rates. This diversity complicates the development of vaccines that can offer comprehensive and long-lasting protection. Continual pathogen evolution necessitates constant updates in vaccine formulations, increasing research and development costs. Moreover, the unpredictable emergence of novel variants can outpace the availability of suitable vaccines, undermining disease control efforts and adding uncertainty to vaccine efficacy.

Key Market Trends

Precision Vaccination

Precision vaccination is emerging as a key trend in the poultry vaccines market, with the focus shifting toward more targeted and efficient immunization strategies. This approach tailors vaccination programs based on specific factors such as the age, health status, and risk profile of poultry flocks. Through the use of data analytics and advanced monitoring systems, precision vaccination enables better disease forecasting and more accurate administration schedules. The result is enhanced vaccine effectiveness, reduced wastage, and cost optimization. This trend aligns with the broader movement toward data-driven, sustainable practices in animal agriculture and reflects the industry's commitment to maximizing productivity while minimizing intervention-related costs.

Key Market Players

  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corporation

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application:

  • Broiler
  • Layer
  • Breeder

Poultry Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Poultry Vaccines Market, By Disease Type:

  • Infectious Bronchitis
  • Infectious Bursal Diseases
  • Infectious Laryngotracheitis
  • Egg Drop Syndrome
  • Adenovirus
  • Duck Viral Enteritis
  • Inclusion Body Hepatitis
  • Salmonella
  • Others

Poultry Vaccines Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Broiler, Layer, Breeder)
    • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Application
    • 5.3.2. By Product
    • 5.3.3. By Disease Type
    • 5.3.4. By Region

6. North America Poultry Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Broiler, Layer, Breeder)
    • 6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Poultry Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Disease Type
    • 6.3.2. Canada Poultry Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Disease Type
    • 6.3.3. Mexico Poultry Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application (Broiler, Layer, Breeder)
    • 7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Poultry Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Disease Type
    • 7.3.2. United Kingdom Poultry Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Disease Type
    • 7.3.3. France Poultry Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Disease Type
    • 7.3.4. Italy Poultry Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Disease Type
    • 7.3.5. Spain Poultry Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Poultry Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application (Broiler, Layer, Breeder)
    • 8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Poultry Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Disease Type
    • 8.3.2. Japan Poultry Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Disease Type
    • 8.3.3. India Poultry Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Disease Type
    • 8.3.4. Australia Poultry Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Disease Type
    • 8.3.5. South Korea Poultry Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Disease Type

9. South America Poultry Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application (Broiler, Layer, Breeder)
    • 9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Poultry Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Disease Type
    • 9.3.2. Argentina Poultry Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Disease Type
    • 9.3.3. Colombia Poultry Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Poultry Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application (Broiler, Layer, Breeder)
    • 10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Poultry Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Disease Type
    • 10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Disease Type
    • 10.3.3. UAE Poultry Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Boehringer Ingelheim GmbH
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Zoetis Inc
  • 14.3. Elanco LLC
  • 14.4. Intervet Inc
  • 14.5. Hester Biosciences Ltd
  • 14.6. Vaxxinova GmbH
  • 14.7. Venky's India Ltd
  • 14.8. Laboratorios Calier SA
  • 14.9. KM Biologics Co Ltd
  • 14.10. Phibro Animal Health Corporation

15. Strategic Recommendations

16. About Us & Disclaimer